Please use this identifier to cite or link to this item: https://hdl.handle.net/10216/157225
Full metadata record
DC FieldValueLanguage
dc.creatorBahare Salehi
dc.creatorNatália Cruz-Martins
dc.creatorMonica Butnariu
dc.creatorIoan Sarac
dc.creatorIulia-Cristina Bagiu
dc.creatorShahira M. Ezzat
dc.creatorJinfan Wang
dc.creatoroutros
dc.date.accessioned2024-08-21T23:08:12Z-
dc.date.available2024-08-21T23:08:12Z-
dc.date.issued2022
dc.identifier.issn1040-8398
dc.identifier.othersigarra:660283
dc.identifier.urihttps://hdl.handle.net/10216/157225-
dc.language.isoeng
dc.rightsrestrictedAccess
dc.titleHesperetin's health potential: moving from preclinical to clinical evidence and bioavailability issues, to upcoming strategies to overcome current limitations
dc.typeArtigo em Revista Científica Internacional
dc.contributor.uportoFaculdade de Medicina
dc.identifier.doi10.1080/10408398.2021.1875979
Appears in Collections:FMUP - Artigo em Revista Científica Internacional

Files in This Item:
File Description SizeFormat 
660283.pdf
  Restricted Access
2.13 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.